期刊文献+

紫草素调控MicroRNA-382-5p抑制人增生性瘢痕成纤维细胞纤维化 被引量:2

Shikonin inhibits fibrosis of human hypertrophic scar fibroblasts via MicroRNA-382-5p
下载PDF
导出
摘要 背景:目前已有研究表明紫草素具有治疗增生性瘢痕的潜力,且miRNA参与增生性瘢痕的病理机制调控,猜测紫草素有可能通过影响miRNA调控增生性瘢痕的发生发展。目的:探讨紫草素通过影响MicroRNA-382-5p对人增生性瘢痕成纤维细胞纤维化的作用机制。方法:收集宁夏医科大学总医院烧伤整形外科提供的增生性瘢痕组织及瘢痕旁正常皮肤组织(瘢痕旁3 cm以内),并分别分离出人增生性瘢痕成纤维细胞和正常成纤维细胞用于后续实验。苏木精-伊红染色鉴定正常皮肤和增生性瘢痕;免疫荧光鉴定成纤维细胞;采用实时荧光定量PCR从组织水平检测MicroRNA-382-5p相对表达水平。将增生性瘢痕成纤维细胞随机分为紫草素组(紫草素溶于二甲基亚砜配成浓度为13.46μmol/L的药物干预细胞24 h)、二甲基亚砜组、MicroRNA-382-5p阴性对照组、MicroRNA-382-5p抑制组、紫草素+MicroRNA-382-5p阴性对照组及紫草素+MicroRNA-382-5p过表达组。实时荧光定量PCR检测Ⅰ型胶原蛋白α1、Ⅲ型胶原蛋白α1和α-平滑肌肌动蛋白mRNA表达;Western blot检测Ⅰ型胶原蛋白α1、Ⅲ型胶原蛋白α1和α-平滑肌肌动蛋白的蛋白表达;CCK-8法检测细胞活性;划痕实验检测细胞迁移能力。结果与结论:①与正常皮肤成纤维细胞相比,增生性瘢痕成纤维细胞增殖活性更强(P<0.01);②与二甲基亚砜组相比,紫草素组可以下调增生性瘢痕成纤维细胞中Ⅰ型胶原蛋白α1、Ⅲ型胶原蛋白α1和α-平滑肌肌动蛋白的表达水平(mRNA:P<0.01,蛋白:P<0.01),并抑制增生性瘢痕成纤维细胞迁移(P<0.05);③与正常皮肤相比,MicroRNA-382-5p在增生性瘢痕中呈高表达(P<0.01),且紫草素能下调增生性瘢痕成纤维细胞中MicroRNA-382-5p的表达(P<0.01);④敲低MicroRNA-382-5p能下调增生性瘢痕成纤维细胞中Ⅰ型胶原蛋白α1、Ⅲ型胶原蛋白α1和α-平滑肌肌动蛋白的表达水平(mRNA:P<0.01,蛋白:P<0.01),并抑制增生性瘢痕成纤维细胞迁移(P<0.05);⑤过表达MicroRNA-382-5p能上调在紫草素影响下增生性瘢痕成纤维细胞中Ⅰ型胶原蛋白α1、Ⅲ型胶原蛋白α1和α-平滑肌肌动蛋白的表达水平(mRNA:P<0.01,蛋白:P<0.01),并促进增生性瘢痕成纤维细胞迁移(P<0.01);⑥提示紫草素可通过下调MicroRNA-382-5p的表达抑制增生性瘢痕成纤维细胞的纤维化和迁移。 BACKGROUND:Previous studies have shown that shikonin has the potential to treat hypertrophic scar and that microRNAs are involved in the regulation of the pathological mechanism of hypertrophic scar.It is speculated that shikonin may regulate the occurrence and development of hypertrophic scar through microRNAs regulation.OBJECTIVE:To investigate the mechanism of shikonin on the fibrosis of human hypertrophic scar fibroblasts via MicroRNA-382-5p.METHODS:Hypertrophic scar tissue and normal skin tissue adjacent to the scar(within 3 cm around the scar)were provided by the Department of Burn and Plastic Surgery,General Hospital of Ningxia Medical University to extract human hypertrophic scar fibroblasts and human normal skin fibroblasts,respectively.Hematoxylin-eosin staining was used to identify normal skin and hypertrophic scar and immunofluorescence was used to identify fibroblasts.The relative expression level of MicroRNA-382-5p was detected by quantitative real-time PCR at the tissue level.Hypertrophic scar fibroblasts were randomly divided into shikonin group(shikonin was dissolved in dimethyl sulfone to make drug solution at a concentration of 13.46μmol/L,which was used for cell culture for 24 hours),dimethyl sulfone group,MicroRNA-382-5p negative control group,MicroRNA-382-5p inhibitor group,shikonin+MicroRNA-382-5p negative control group and shikonin+MicroRNA-382-5p overexpression group.Real-time fluorescence quantitative PCR and western blot were used to detect the expression of Collagen Type Iα1,Collagen Type IIIα1 andα-smooth muscle actin at mRNA and protein levels,respectively.Cell counting kit-8 was used to detect cell viability.Cell scratch test was used to detect the migration ability of cells.RESULTS AND CONCLUSION:Compared with normal skin fibroblasts,hypertrophic scar fibroblasts had stronger proliferative activity(P<0.01).Compared with the dimethyl sulfone group,shikonin down-regulated the expression levels of Collagen Type Iα1,Collagen Type IIIα1 andα-smooth muscle actin in human hypertrophic scar fibroblasts(mRNA:P<0.01,protein:P<0.01),and inhibited the migration of hypertrophic scar fibroblasts(P<0.05).Compared with normal skin,MicroRNA-382-5p was highly expressed in hypertrophic scar(P<0.01),and shikonin could down-regulate the expression of MicroRNA-382-5p(P<0.01).Inhibition of MicroRNA-382-5p down-regulated the expression level of Collagen Type Iα1,Collagen Type IIIα1 andα-smooth muscle actin in hypertrophic scar fibroblasts(mRNA:P<0.01,protein:P<0.01),and inhibited the migration of hypertrophic scar fibroblasts(P<0.05).Under the influence of shikonin,overexpression of MicroRNA-382-5p upregulated the expression levels of Collagen Type Iα1,Collagen Type IIIα1 andα-smooth muscle actin in hypertrophic scar fibroblasts(mRNA:P<0.01,protein:P<0.01),and promoted the migration of hypertrophic scar fibroblasts(P<0.01).To conclude,shikonin can inhibit the fibrosis and migration of hypertrophic scar fibroblasts by down-regulating the expression of MicroRNA-382-5p.
作者 唐玉婷 贺茜 万瑀 王建军 杨安宁 吴凯 焦运 白志刚 姜怡邓 沈江涌 Tang Yuting;He Xi;Wan Yu;Wang Jianjun;Yang Anning;Wu Kai;Jiao Yun;Bai Zhigang;Jiang Yideng;Shen Jiangyong(Clinical College of Medicine,Yinchuan 750004,Ningxia Hui Autonomous Region,China;National Key Laboratory of Metabolic Cardiovascular Disease Research,Yinchuan 750004,Ningxia Hui Autonomous Region,China;Department of Burn and Plastic Surgery,General Hospital of Ningxia Medical University,Yinchuan 750004,Ningxia Hui Autonomous Region,China;Basic Medical College,Ningxia Medical University,Yinchuan 750004,Ningxia Hui Autonomous Region,China;Department of Infection,General Hospital of Ningxia Medical University,Yinchuan 750004,Ningxia Hui Autonomous Region,China;Department of Orthopedics,Ningxia Hui Autonomous Region People’s Hospital,Yinchuan 750004,Ningxia Hui Autonomous Region,China)
出处 《中国组织工程研究》 CAS 北大核心 2023年第35期5642-5648,共7页 Chinese Journal of Tissue Engineering Research
基金 国家自然科学基金(U21A20343),项目负责人:姜怡邓 国家自然科学基金(81860555),项目负责人:沈江涌 中国医学科学院中央级公益性科研院所基本科研业务费项目(2019PT330002),项目负责人:姜怡邓 宁夏回族自治区重点研发计划重点项目(2020BFH02003),项目负责人:杨安宁 宁夏回族自治区重点研发计划重点项目(2020BFH02001),项目负责人:白志刚 宁夏回族自治区重点研发计划重点项目(2021BEG02028),项目负责人:吴凯 宁夏高等学校一流学科建设(宁夏医科大学国内一流建设学科临床医学)资助项目(NXYLXK2017A05),项目负责人:沈江涌。
关键词 紫草素 MicroRNA-382-5p 增生性瘢痕 正常皮肤 成纤维细胞 胶原沉积 细胞迁移 shikonin MicroRNA-382-5p hypertrophic scar normal skin fibroblast collagen deposition cell migration
  • 相关文献

参考文献4

二级参考文献33

  • 1Zhensen Zhu,Jie Ding,Edward E.Tredget.The molecular basis of hypertrophic scars[J].Burns & Trauma,2016,4(1):1-12. 被引量:11
  • 2黄云虹,张胜华,甄瑞贤,许先栋,甄永苏.积雪草甙诱导肿瘤细胞凋亡及增强长春新碱的抗肿瘤作用[J].癌症,2004,23(12):1599-1604. 被引量:49
  • 3Eleni Zygalaki,Ailki Stathopoulou,Christos Kroupis,et al.Real-Time Reverse Transcription-PCR Quantification of Vascular Endothelial Growth Factor splice Variants[J].Clinical Chemistry,2005,51(8):1 518-1 520.
  • 4Zhu KQ,Engrav LH,Armendariz R,et al.Changes in VEGF and nitric oxide after deep dermal iniury in the female,red Duroc pig-further similarities between female.Duroc scar and human hypertrophic scar[J].Burns,2005,31:5-10.
  • 5Nissen NN,Polverini PJ,Koch AE,et al.VEGF mediate angiogenic activty during the proliferative phase of wound healing[J].Am J Pathol,1998,152:1 445-1 452.
  • 6Schwarz ER,Speakman MT,Patterson M,et al.Evaluation of the efects of intramyocardial injection of DNA expressing vascular endothelial growth factor(VEGF)in a myocardial infarction in the mt-angiogenesis and angioma formation[J]J Am Coil Cardiol,2000,35:1 323-1 330.
  • 7Gauglitz G G, Korting H C, Pavicic T, et al. Hypertrophic scar- ring and keloids : pathomechanisms and current and emerging treat- ment strategies[J]. Mol Med, 2011, 17(1 -2) : 113 -25.
  • 8Penn J W, Grobbelaar A O, Relfe K J. The role of the TGF-beta family in wound healing, bums and scarring: a review[J]. Int J Burns Trauma, 2012, 2( 1 ): 18- 28.
  • 9Nakerakanti S S, Bnjor A M, Yrojannwska M. CCN2 is required for the TGF-beta induced activation of Smadl-Erkl/2 signaling network[J]. PLoS One, 2011, 6(7) : e21911.
  • 10Visse R, Nagase H. Matrix metallopmteinases and tissue inhibitom of metalloproteinases : structure, function, and biochemistry [ J ]. Cite Res, 2003, 92(8) : 827.

共引文献35

同被引文献13

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部